Thanks @Target2017
JW Therapeutics (HKEX 2126) is an innovative biotech company focusing on immunotherapy products in China. It was co-founded by Juno Therapeutics (BMS subcompany MC$130B usd) and Wuxi AppTec (MC $62B usd, after spin out the Wuxi Biologics MC$65B usd)
I can imagine we are already attracted by those big Chinese pharm/investors.
Roth Capital new (12 months) target @62c (from 43c 4months ago)
Exciting time till Xmas
- CF33 2nd patient dosed
- Vaxinia IND
- Hervaxx new study and sponsorship
- Hervaxx OS data
- PD1Vaxx cohort 3 update
Thanks @Target2017JW Therapeutics (HKEX 2126) is an innovative...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.8¢ | 5.6¢ | $1.040M | 18.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1917207 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 653942 | 7 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |